NMR-Based Metabolomic Analysis on the Protective Effects of Apolipoprotein A-I Mimetic Peptide against Contrast Media-Induced Endothelial Dysfunction
Open Access
Abstract
Endothelial dysfunction plays key roles in the pathological process of contrast media (CM)-induced acute kidney injury (CI-AKI) in patients undergoing vascular angiography or intervention treatment. Previously, we have demonstrated that an apolipoprotein A-I (apoA-I) mimetic peptide, D-4F, inhibits oxidative stress and improves endothelial dysfunction caused by CM through the AMPK/PKC pathway. However, it is unclear whether CM induce metabolic impairments in endothelial cells and whether D-4F ameliorates these metabolic impairments. In this work, we evaluated vitalities of human umbilical vein endothelial cells (HUVECs) treated with iodixanol and D-4F and performed nuclear magnetic resonance (NMR)-based metabolomic analysis to assess iodixanol-induced metabolic impairments in HUVECs, and to address the metabolic mechanisms underlying the protective effects of D-4F for ameliorating these metabolic impairments. Our results showed that iodixanol treatment distinctly impaired the vitality of HUVECs, and greatly disordered the metabolic pathways related to energy production and oxidative stress. Iodixanol activated glucose metabolism and the TCA cycle but inhibited choline metabolism and glutathione metabolism. Significantly, D-4F pretreatment could improve the iodixanol-impaired vitality of HUVECs and ameliorate the iodixanol-induced impairments in several metabolic pathways including glycolysis, TCA cycle and choline metabolism in HUVECs. Moreover, D-4F upregulated the glutathione level and hence enhanced antioxidative capacity and increased the levels of tyrosine and nicotinamide adenine dinucleotide in HUVECs. These results provided the mechanistic understanding of CM-induced endothelial impairments and the protective effects of D-4F for improving endothelial cell dysfunction. This work is beneficial to further exploring D-4F as a potential pharmacological agent for preventing CM-induced endothelial impairment and acute kidney injury.Keywords
Funding Information
- National Natural Science Foundation of China (31971357, 31670741)
This publication has 50 references indexed in Scilit:
- Iodinated Contrast Media Can Induce Long-Lasting Oxidative Stress in Hemodialysis PatientsYonsei Medical Journal, 2013
- Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferationProceedings of the National Academy of Sciences, 2012
- Human apolipoprotein A-I induces cyclooxygenase-2 expression and prostaglandin I-2 release in endothelial cells through ATP-binding cassette transporter A1American Journal of Physiology-Cell Physiology, 2011
- Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar RatsPLOS ONE, 2011
- Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced NephropathyInvestigative Radiology, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Low osmolar contrast medium induces cellular injury and disruption of calcium homeostasis in rat glomerular endothelial cells in vitroToxicology Letters, 2009
- Premature senescence of human endothelial cells induced by inhibition of glutaminaseBiogerontology, 2008
- Protection of Endothelial Function: Targets for Nutritional and Pharmacological InterventionsJournal of Cardiovascular Pharmacology, 2006
- Iodinated radiographic contrast media inhibit shear stress‐ and agonist‐evoked release of NO by the endotheliumBritish Journal of Pharmacology, 1999